Stevens Capital Management LP Bristol Myers Squibb CO Transaction History

Stevens Capital Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $607,381 - $679,147	-10,492 Reduced 39.46%	16,098 $934,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.4 Million - $1.56 Million	22,025 Added 482.48%	26,590 $1.7 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $299,966 - $340,229	4,565 New	4,565 $316,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $2.14 Million - $2.49 Million	-39,862 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $2.36 Million - $2.76 Million	39,862 New	39,862 $2.36 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $1.16 Million - $1.26 Million	-18,694 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $1.11 Million - $1.25 Million	18,694 New	18,694 $1.18 Million
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $4.88 Million - $7.09 Million	-105,145 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $1.05 Million - $1.37 Million	21,410 Added 25.57%	105,145 $6.75 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $4.45 Million - $5.28 Million	-104,070 Reduced 55.41%	83,735 $4.25 Million
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $1.75 Million - $1.93 Million	-39,149 Reduced 17.25%	187,805 $8.52 Million
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $10.2 Million - $12.2 Million	226,954 New	226,954 $10.8 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.